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Abstract
Background
Normal thyroid function is essential for general growth and metabolism, but can be affected
by endocrine disrupting chemicals (EDCs). Polybrominated diphenyl ethers (PBDEs) have
been used worldwide to reduce flammability in different materials and are suspected to be
EDCs. The production of the commercial Penta- and OctaBDE mixtures is banned, but Dec-
aBDEs and existing products may leak PBDEs into the environment. Our aim was to investi-
gate the effect of the PentaBDE mixture DE-71 on human thyroid cells in vitro.
Materials and methods
Primary human thyroid cells were obtained as paraadenomatous tissue and cultured in
monolayers. The influence of DE-71 on cyclic adenosine monophosphate (cAMP) and thy-
roglobulin (Tg) production was examined in the culture medium by competitive radioimmu-
noassay and enzyme-linked immunosorbent assay, respectively. Real-time quantitative
PCR analysis of thyroid-specific genes was performed on the exposed cell cultures. PBDE
concentrations were determined in cellular and supernatant fractions of the cultures.
Results
DE-71 inhibited Tg-release from TSH-stimulated thyrocytes. At 50 mg/L DE-71, mean Tg
production was reduced by 71.9% (range: 8.5–98.7%), and cAMP by 95.1% (range: 91.5–
98.8%) compared to controls). Expression of mRNA encoding Tg, TPO and TSHr were sig-
nificantly inhibited (p<0.0001, p = 0.0079, and p = 0.0002, respectively). The majority of DE-
71 added was found in the cell fraction. No cytotoxicity was found.
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Conclusions
DE-71 inhibited differentiated thyroid cell functions in a two phase response manner and a
concentration-dependent inhibition of Tg and cAMP production, respectively, as well as
expression of mRNA encoding Tg, TPO and TSHr. Our findings suggest an inhibiting effect
of PBDEs on thyroid cells.
Introduction
Polybrominated diphenyl ethers (PBDEs) have been used as flame retardants to reduce flam-
mability of electronic equipment, upholstery, textiles, plastics and building materials [1]. Com-
mercial production of the PentaBDE and OctaBDE mixtures was banned in the European
Union in 2004 and phased out in the USA in 2005 [1–4], due to increasing concerns of adverse
physiological effects and persistence of the compounds [5–7]. Since 2009, the Penta- and
OctaBDE mixtures have been registered as global persistent organic pollutants under the
Stockholm Convention [8]. However, because of a long life-time PBDEs will continue to leak
from products and accumulate in the environment and humans for many years [1;9]. DE-71
was one of the commercial PentaBDE mixtures, mainly consisting of the tetra-, penta-, and
hexabrominated congeners [10]. The congener pattern of commercial PentaBDE mixtures is
reflected in indoor dust and air, and the congeners are found in human samples, such as
blood, placenta, amniotic fluid and breast milk [11;12].
The PBDEs are believed to be toxic at low concentrations [1]. Epidemiological studies indi-
cate neurobehavioral and developmental effects as well as effects on the reproductive and
endocrine system. Animal and in vitro studies have also shown effects of PBDEs on the
immune system [13–15]. PBDEs are classified as possible endocrine disrupting chemicals
(EDCs) [16;17]. Some EDCs are suspected to affect thyroid function, thereby resulting in thy-
roid homeostasis disturbances [18]. The thyroid gland produces the thyroid hormones thyrox-
ine (T4) and triiodothyronine (T3), which are essential for growth, metabolism and brain
development. The protein molecule thyroglobulin (Tg) in thyrocytes is precursor for thyroid
hormone production. Thyroid peroxidase catalyses oxidation of iodine, which is necessary for
correct thyroid hormone synthesis on the Tg precursor. However, many targets are available
for possible disruption of thyroid function [18;19]. Hyper- as well as hypo-secretion of thyroid
hormones affect multiple organ systems. Some PBDEs penetrate the placenta [20;21] and
thereby may have a damaging effect on the development of neurological functions in embryos
[22–24]. Moreover, children are particularly sensitive to changes in thyroid homeostasis [17]
and more exposed than adults, since PBDEs are present in breast milk [1], and children likely
have a larger uptake of PBDEs with dust [1;25] and an immature metabolic capacity [26]. Sev-
eral epidemiologic studies in humans and wildlife suggest a correlation between PBDE expo-
sure and altered thyroid homeostasis [13;26–29]. Neurodevelopmental effects resulting from
PBDE exposure of children might have consequences for society, in terms of lower IQ levels
and associated costs [27].
The direct effects of PBDEs on the thyroid gland are unknown, and we therefore aimed to
study effects and cytotoxicity of the commercial mixture DE-71 on primary human thyroid
cell function. This was investigated via analysis of protein secretion and gene expression in the
differentiated thyroid cells. We hypothesised that PBDEs would disturb these functions.
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Materials and methods
Cell cultures
Preparation of cells took place as previously described [30] with minor modifications. In sum-
mary, primary human thyroid cells were obtained as paraadenomatous tissue (assumed to be
normal) from thyroidectomies performed at the department of Ear Nose Throat (ENT)-Head
and Neck surgery, Rigshospitalet, University of Copenhagen. The thyroid tissue was cut into
small pieces, and the cells were separated from connective tissue by incubation with collage-
nase I (Sigma-Aldrich, St. Louis, MO, USA) and dispase II (Roche, Basel, Switzerland) for
60–90 min. at 37˚C. The digested tissue was filtered, culture medium was added and the sus-
pension was centrifuged at 1200 x G for five min. The cells were cultured in 24-well plates con-
taining HAM’s F-12 media (Panum Institute, Copenhagen University, Denmark)
supplemented with 5% fetal bovine serum (FBS) (Biological Industries, Beit HaEmek, Israel),
1% L-glutamine (Panum Institute, Copenhagen University, Denmark), 1% non-essential
amino acids (Gibco, Invitrogen, Carlsbad, CA, USA), 1% penicillin and streptomycin (Invitro-
gen), and six nutritional factors (6H media): 1 IU/L bovine thyroid stimulating hormone
(TSH) (Sigma-Aldrich), human insulin; 10 mg/L (rhinsulin; Humulin, Eli Lilly), 6 mg/L trans-
ferrin (Sigma-Aldrich), 0.01 mg/L Gly-His-Lys acetate (Sigma-Aldrich), 10 mg/L somatostatin
(Calbiochem), 10−8 M hydrocortisone (Calbiochem). Cells were grown until a confluent
monolayer was visualized in the wells. The growth period lasted for a maximum of 10 days in
order to avoid loss of properties of the cells [31]. The suitability of each cell culture to study cel-
lular functions was ensured by assessing outcome variables from both TSH- and un-stimulated
cells.
DE-71 exposure
Cell monolayers were cultured for three additional days without TSH (5H medium) before
stimulation and addition of DE-71 in serum free medium for 72 hours. DE-71 (pentaBDE, lot
7550K20A was kindly provided by Martha Axelstad, National Food Institute, Technical Uni-
versity of Denmark and Dr. Kevin Crofton of the U.S. Environmental Protection Agency),
was dissolved in dimethyl sulfoxide (DMSO, D2438 Sigma-Aldrich, St. Louis, MO, USA)
prior to dissolving in culture medium without FBS, resulting in final concentrations of 0.01,
0.1, 1, 5, 10 and 50 mg DE-71/L, respectively, and 1 ‰ DMSO in the cell cultures. Three
negative controls (without DE-71) were included on each culture plate: one non-stimulated
(5H medium) without DMSO and two TSH-stimulated (6H medium) cell populations,
respectively, with and without 1 ‰ DMSO added. All experiments were conducted in dupli-
cate in the culture plates. The cell function is dependent on TSH, which was assessed by com-
paring 6H and 5H controls. Cells were visually inspected by light microscopy at the end of
incubation. Cell supernatants were harvested and stored at -20˚C until analyses. The cells
were harvested on ice, immediately after removal of the cell supernatant using lysis buffer
(Qiagen, Hilden, Germany) and stored at -80˚C with prior addition of 70% ethanol (350 μL
pr. well).
Cell function analysis
The function of the cells was evaluated by measuring the second messenger cyclic adenosine
monophosphate (cAMP) and Tg concentrations in the cell supernatants. cAMP and Tg were
analyzed as previously described by a competitive protein binding method detected by a radio-
immunoassay (RIA) and an enzyme-linked immunosorbent assay (ELISA), respectively
[30;32]. To assess cAMP production, 3-isobutyl-1-methylxanthine was diluted in ethanol
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(final ethanol concentration 1%) and added to the cultures concurrently with DE-71 solutions.
The Tg assay was designed to measure Tg in culture medium and not for use in serum. Tg and
cAMP analysis were each performed on seven cultures, representing seven patients, each on
one 24-well plate. In total, tissue was obtained from 11 patients (nine females, two males, age:
20–82 years). Three tissue samples contained an amount of cells eligible for growth on two
24-well plates, why each of these three samples gave rise to one culture for Tg and one culture
for cAMP analysis.
The intra-assay variation of the cAMP method was 4.9% at 0.5 μM and 3.2% at 1.57 μM and
the inter-assay variation was 24.8% for the low control (range 0.38–0.66 μM) and 11.5% for the
high control (range 1.34–1.77 μM) (n = four duplicates for each control). The calibration
range was 0.05 to 2.0 μM.
The intra-assay variation of the Tg-analysis was 7.3% and 10.9% at 55 and 116 μg/L, respec-
tively, and the inter-assay variation was 22.6% for the low control (range 32.3–63.5 μg/L) and
26.2% for the high control (74.7–149.1 μg/L) (n = six samples in duplicate for each type of con-
trol, see DE-71 exposure). The calibration range was 10 to 500 μg/L.
Real-time quantitative polymerase chain reaction (RT-qPCR)
Cell function analysis was also carried out by determining the gene expression of Tg,
thyroid peroxidase (TPO), sodium iodine symporter (NIS), thyroid stimulating hormone
receptor (TSHr) and interleukin (IL)-6. IL-6 is secreted from human thyroid cells as shown
earlier [33], but it is not expressed in differentiated thyrocytes and thus served as negative
control.
Total RNA from harvested primary human thyroid cells from five cultures (cell remnants
from cultures used for Tg analysis) was extracted with Rneasy Mini Kit (Qiagen) according to
the manufacturer’s protocol. The concentration and purity of the achieved RNA was measured
on a NanoDrop spectrophotometer (nd-1000, Wilmington, DE, USA). cDNA was synthesized
(Superscript VILO synthesis kit (Invitrogen) by mixing four μL of the VILO reaction mix,
two μL of the Superscript enzyme mix, the RNA from each sample and RNAase free water to a
total volume of 20 μL. The volume of added RNA was adjusted to unify the final concentration
of RNA in all samples from the same cell culture. Samples were incubated for 10 min. at 25˚C,
60 min. at 50˚C and 5 min. at 85˚C, after which 80 μL of 0.5X Tris-EDTA-buffer (Sigma-
Aldrich) were added. For real-time quantitative polymerase chain reaction (RT-qPCR), SYBR
Green JumpStart Taq Ready Mix (Sigma-Aldrich) was used. Primers and their respective
sequences are listed in Table 1. The primers were validated by SYBR melting curves and the
qPCR fragment sizes were checked on agarose gels. A pool of undiluted cDNA was used for
standards. To each reaction, 4 μL of the SYBR Green JumpStart Taq ReadyMix, 10 μL H2O
and 1 μL primermix (1μM final concentration of each primer) were added. RT-qPCR was
done on Lightcycler 480 II (Roche) with the following cycling: Initial denaturation at 94˚C for
two min., followed by 45 cycles of 30 seconds at 94˚C, 45 seconds at 59˚C and 1.5 min. at
72˚C, and finally melting curve analysis. The high number of cycles was used due to very low
expression of both NIS and IL-6. The specificity of the amplified products was verified by melt-
ing curve analysis and the relative mRNA quantification was achieved by standard curve
method. The obtained gene of interest-expression was then divided by the housekeeping gene
-expression of the same sample. Neither DE-71, TSH nor DMSO had any influence on these
housekeeping genes. Using GENORM-calculation on the gene expression of B2M, GAPDH
and ACTB, the last two were the most stable genes and the genes of interest were therefore
normalized to the geometric mean of GAPDH and ACTB.
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Cytotoxicity
DE-71 induced cytotoxicity was analysed by assessing the content of lactate dehydrogenase
(LDH) in cell culture supernatants as described previously [34]. For this purpose, a homoge-
nous membrane integrity assay, CytoTox-ONE (Promega, Fitchburg, WI, USA), was used
according to the manufacturer’s protocol with the modification that LDH was not measured
directly in cell cultures but in harvested supernatants. Briefly, one experiment was performed
with cell culture supernatants from an experiment containing single determinations of six
DE-71 concentrations (0.01; 0.1; 1; 5; 10 and 50 mg DE-71/L) and duplicates of the negative
controls (6H medium with and without 1‰ DMSO and 5H medium) and positive controls
(0.02, 0.2 and 1.9 mg/L Triton X-100). The frozen cell supernatants were thawed and mixed
by vortex. Fifty μL of each culture media sample were transferred to a 96-wells micro plate
(Th.Geyer, Renningen, Germany) followed by addition of the same volume CytoTox-One
reagent to all wells. The micro plate was mixed gently on a shaker and incubated at room tem-
perature for 10–15 min. Twenty-five μl stop solution were added, and the plate was mixed
again on a shaker before results were read on a fluorometer (Victor2, PerkinElmer, Waltham,
MA, USA). The LDH content was expressed proportional to the produced fluorescence and
given in relative fluorescence units. The cytotoxicity kit passed quality control assays according
to the manufacturer.
PBDE analysis
Three supernatants and three cell samples of pooled triplicates (addition of 0.01, 10 and 50
mg/L, respectively), one 1‰ DMSO control supernatant sample, one 1‰ DMSO control cell
sample, three standard solutions of DE-71 in DMSO (0.01, 5 and 50 mg/L) and two solutions
of DE-71 in cell media were analysed for content and composition of BDE-congeners at Aar-
hus University, Department of Environmental Science. This was done after the function analy-
ses using once thawed samples. The measurements followed accredited methods for PBDEs in
biota as described elsewhere [35] and included 11 tri- to heptabrominated congeners (BDE-17,
28, 47, 49, 66, 85, 99, 100, 153, 154 and 183). Inter-batch variation of the in-house reference
Table 1. Sequences of the primers used in RT-qPCR.
Gene Direction Sequence
Tg forward GGGCGGGCAGTCAGCAGAGAGTG
reverse CCATAGTGGGCAGCCTCGGGTGAG
TPO forward GGAGAGTGCTGGGATGGAAG
reverse GGATTTGCCTGTGTTTGGAA
SLC5A5 (NIS) forward ACCTTCTACACGGCTGTGGGCGGC
reverse CTCGGGTCAGGGTTAAAGTCCATG
TSHr forward GAATGCTTTTCAGGGACTATGCAAT
reverse ACAGCAGTGGCTTGGGTAAGAA
IL-6 forward AGAGTAACATGTGTGAAAGCAGCAA
reverse CCTCAAACTCCAAAAGACCAGTGA
B2M forward TGTGCTCGCGCTACTCTCTC
reverse CTGAATGCTCCACTTTTTCAATTCT
ACTB forward CTGGAACGGTGAAGGTGACA
reverse AAGGGACTTCCTGTAACAACGCA
GAPDH forward CATGAGAAGTATGACAACAGCCT
reverse AGTCCTTCCACGATACCAAAGT
https://doi.org/10.1371/journal.pone.0179858.t001
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material (n = 18), sand eel oil, ranged from 2.7% (BDE-47) to 14% (BDE-17), with a mean of
6.6% for all congeners. The instrumental detection limits ranged between 0.05 and 0.25 pg.
Briefly, all samples (except for the three standard solutions of DE-71 in DMSO) were spiked
with recovery standards, dried with diatomaceous earth (Varian) and Soxhlet extracted with
hexane:acetone (4:1). The extracts were cleaned up on a multilayer column consisting of alu-
minum oxide, silica and acidified silica. After elution, volume reduction and addition of the
internal standard (BDE-71, Cambridge Isotope Laboratories, Tewksbury, MA, USA), the sam-
ples were analysed by gas chromatography—mass spectrometry (GC-MS) with electron cap-
ture negative ionization. Quantification was based on two calibrations of ten standards each
(0.05–25 ng/mL). The samples were extracted in three batches, each also containing 1–2 spiked
control samples (approximately 10 ng of the individual congeners) and one blank. The three
DE-71 stock solutions in DMSO, along with four spiked control samples (approximately 10 ng
of the individual congeners) and two blanks, were evaporated to dryness in silicone vials [35],
re-dissolved in iso-octane including the internal standard BDE-71 and analysed without fur-
ther clean-up.
Statistics
For analysis of cAMP and Tg, culture supernatants were assessed in duplicates from 11differ-
ent patients (total cultures, n = 14). The Tg- and cAMP-productions (mean of duplicates) as
well as gene expression (cells from five different patients, duplicates were pooled before RNA
extraction) were analysed by two way ANOVA followed by Tukey’s honest significant differ-
ence post hoc analysis to compare experiment groups (R, version 3.1.2). Ln-transformed data
was used when necessary. Results from the Tukey analysis are given as estimated differences
between groups in tables.
The responses from TSH-stimulated cells with and without DMSO were compared by
paired t-tests to investigate if DMSO had an isolated effect on stimulated thyroid cells. Appro-
priate responsiveness of the thyrocytes to TSH was demonstrated by comparing Tg and cAMP
release from unstimulated (5H) and TSH-stimulated (6H) cells, respectively (paired t-test).
Values below limit of detection (LOD) in the Tg analysis were replaced by the lowest stan-
dard value in the assay while undetectably low single cAMP concentrations were replaced by
half the cAMP level of lowest detectable value in the assay. These differences were performed
according to the different assay methods. Results were considered statistically significant when
p< 0.05.
Ethics
The study was approved by The Danish committees on health research ethics, Capital region
(Protocol number: H-1-2012-110 and additional protocol 44717). Paraadenomatous tissue
samples were obtained from patients undergoing thyroidectomies. Patients gave oral and writ-
ten informed consent prior to surgery. The paraadenomatous tissue was selected by the chief
surgeon during the procedure.
Results
Quality control of the cells
Inspection of the cell cultures by light microscopy demonstrated that DE-71 formed intracellu-
lar black granula in a concentration-dependent manner, with most granula observed in the
wells exposed to 50 mg DE-71/L and none in the controls. Cell confluence was not affected by
DE-71 addition, indicating that viability was not affected. TSH-responsiveness with
DE-71 inhibits human thyroid cell function
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stimulation of the thyrocytes was ensured by consistent stimulation of cAMP when cultured in
medium with TSH compared to medium without TSH (p = 0.029,).
Tg production
No significant difference was found between the TSH-stimulated production of Tg by thyro-
cytes in DMSO- and culture media controls, respectively (p = 0.13). The DMSO-control
(median = 88.3 μg Tg per L, range: 16.7–2,399 μg/L) was used as negative control in all further
statistical calculations as DE-71 was dissolved in DMSO, thereby making DE-71 the only dif-
ference between control and experiment.
DE-71 displayed an inhibiting two-phase -response effect on the TSH-induced Tg produc-
tion (Fig 1A) (p<0.0001). Post hoc analysis (Table 2) showed that cultures exposed to 50 mg
DE-71/L contained significantly less Tg than cultures exposed to either 0, 0.01, 0.1 or 1 mg
DE-71/L (p = 0.0002–0.0012).
cAMP production
As shown in Fig 1B, DE-71 also caused inhibition of the TSH-induced production of cAMP, in
a concentration-dependent manner (p<0.0001). The post hoc analysis (Table 3) showed that
Fig 1. Influence of DE-71 on thyroglobulin (1A) and cAMP (1B) production by primary human
thyrocytes. Primary human thyrocyte cultures were incubated with 1 IU/L TSH and 0.01–50 mg DE-71/L,
dissolved in dimethyl sulfoxide (DMSO). After 72 hours, the concentration of thyroglobulin (Tg) and cAMP in
the culture media was measured by ELISA and by radioimmunoassay, respectively, and expressed as a ratio
to the Tg (A)/cAMP (B)-concentration found in cultures exposed to DMSO control devoid of DE-71. One
cAMP experiment resulted in undetectable control values for both duplicates, and the experimental values in
that culture were therefore not eligible for statistical analysis. The dotted line represents the ratio to the
control = 1. Bars and error bars represent mean+SD of seven (A)/six (B) experiments performed in duplicates.
*p<0.05 compared to DMSO control after post hoc analysis, see Table 2.
https://doi.org/10.1371/journal.pone.0179858.g001
Table 2. Tukey honest significance difference post hoc analysis of ln-transformed thyroglobulin (Tg)-
data; Tg-production form TSH-stimulated cells, non-significant differences not shown, p-value com-
paring two different DE-71 concentrations or DE-71 against control, Estimated Ratio: estimate of indi-
vidual difference/interceptin Tg production between different DE-71 concentration exposures
(groups) in TukeyHSD, converted by exponential function, CI: confidence interval.
DE-71 Exposure Comparisons, Tg data p-value Estimated Ratio (95% CI)
50 mg DE-71/L vs. control 0.0002 0.19 (0.07; 0.5)
50 mg DE-71/L vs. 0.01 mg DE-71/L 0.0003 0.19 (0.07; 0.5)
50 mg DE-71/L vs. 0.1 mg DE-71/L 0.0024 0.24 (0.09; 0.7)
50 mg DE-71/L vs. 1 mg DE-71/L 0.0012 0.22 (0.08; 0.6)
https://doi.org/10.1371/journal.pone.0179858.t002
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cultures exposed to 5, 10 and 50 mg DE-71/L contained less cAMP than the DMSO controls,
and significant inhibitions were also found when comparing cAMP production in presence of
DE-71 at a concentration of 50 mg DE-71/L with that observed in presence of 0.01–10 mg DE-
71/L (p<0.0001–0.025).
RT-qPCR
Comparisons of the negative controls without DE-71 with and without TSH showed no signifi-
cant differences for the expression of any gene (Table 4). Median values of all examined thy-
roid-specific genes were higher in TSH-stimulated thyrocytes than in unstimulated controls.
The production of IL-6, on the other hand, was apparently not affected by TSH as expected.
Expression of Tg-mRNA, TPO-mRNA and TSHr-mRNA was inhibited by DE-71 (p<0.0001,
p = 0.0029 and p = 0.00014, respectively), while DE-71 did not influence IL-6-mRNA nor NIS-
mRNA production with statistical significance according to two-way ANOVA and the post
hoc analysis (Fig 2, Table 5). The pattern shown in Fig 2 demonstrates a two phase response for
Tg, TSHr and TPO gene expression. Even though no statistical significant difference was
found for inhibition of NIS, the pattern in Fig 2 is similar for NIS compared to Tg, TSHr and
TPO.
Table 3. Tukey honest significance difference post hoc analysis of ln-transformed cyclic adenosine
monophosphate (cAMP) data; cAMP-production form TSH-stimulated cells, non-significant differ-
ences not shown, p-value comparing two different DE-71 concentrations or DE-71 against control,
cAMP: cyclic adenosine monophosphate, Estimated Ratio: estimate of individual difference/intercept
in cAMP production between different DE-71 concentration exposures (groups) in TukeyHSD, con-
verted by exponential function, CI: confidence interval.
DE-71 Exposure Comparisons, cAMP data p-value Estimated Ratio (95% CI)
5 mg DE-71/L vs. control 0.019 0.13 (0.022; 0.73)
10 mg DE-71/L vs. control 0.007 0.11 (0.020; 0.64)
50 mg DE-71/L vs. control <0.0001 0.019 (0.003; 0.11)
5 mg DE-71/L vs. 0.01 mg DE-71/L 0.025 0.15 (0.026; 0.85)
10 mg DE-71/L vs. 0.01 mg DE-71/L 0.014 0.13 (0.023; 0.74)
50 mg DE-71/L vs. 0.010 mg DE-71/L <0.0001 0.022 (0.004; 0.13)
5 mg DE-71/L vs. 0.1 mg DE-71/L 0.043 0.17 (0.030; 0.96)
10 mg DE-71/L vs. 0.1 mg DE-71/L 0.025 0.15 (0.026; 0.85)
50 mg DE-71/L vs. 0.1 mg DE-71/L <0.0001 0.025 (0.004; 0.14)
50 mg DE-71/L vs. 1 mg DE-71/L <0.0001 0.038 (0.007; 0.22)
50 mg DE-71/L vs. 5 mg DE-71/L 0.025 0.15 (0.026; 0.85)
50 mg DE-71/L vs. 10 mg DE-71/L 0.043 0.17 (0.030; 0.96)
https://doi.org/10.1371/journal.pone.0179858.t003
Table 4. Medians and ranges of gene expression for cell culture media controls, n = number of cultures, p-value comparing 5H gene levels to 6H
gene levels, medians (ranges) for unstimulated controls without TSH and stimulated controls with TSH, respectively. Tg: thyroglobulin, TSHr: thy-
roid stimulating hormone receptor, TPO: thyroid peroxidase, IL-6: interleukin 6, NIS: sodium iodide symporter.
Gene n p-
value
Median (range) of quantified mRNA normalized to
housekeeping gene from unstimulated control, 5H (Control
without TSH)
Median (range) of quantified mRNA noramlized to
housekeeping gene from stimulated control, 6H (Control
with TSH)
Tg 5 0.058 0.49 (0.32; 0.95) 1.15 (0.70; 2.00)
TSHr 5 0.14 0.73 (0.20; 1.43) 1.10 (0.91; 2.43)
TPO 5 0.071 0.31 (0.14; 0.88) 1.21 (0.80; 2.35)
IL-6 5 0.33 10.03 (5.18; 22.90) 8.71 (3.68; 17.99)
NIS 4 0.28 2.95 (1.14; 4.81) 5.34 (3.75; 17.32)
https://doi.org/10.1371/journal.pone.0179858.t004
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The post hoc-analysis revealed an influence from various DE-71 concentrations on Tg-,
TPO- and TSHr gene expression (Table 5). Thus, cultures exposed to 1–50 mg DE-71/L
expressed less Tg than DMSO controls. Significant differences were also found between 0.01
mg DE-71/L and 5–50 mg DE-71/L. The changes in Tg protein and mRNA levels correlated
well with each other.
Cultures exposed to 5–10 mg and 5–50 mg DE-71/L displayed significantly lower expres-
sion of TPO and TSHr, respectively, than controls. Moreover, less TPO-expression occurred
in presence of 10 mg DE-71/L than in presence of 0.01 mg DE-71/L. TSHr expression was
lower in presence of 50 mg/L than in presence of 0.01 mg/L DE-71, and also lower in presence
of 5–50 mg DE-71/L than in presence of 0.1 mg DE-71/L (p-values are listed in Table 5).
Cytotoxicity
We next examined the cytotoxic effect of DE-71. To this end, cultures exposed to Triton X-100
served as positive control. Additions of 0.02, 0.2 or 1.9 mg/L of Triton X-100 caused increases
in LDH concentration of the culture medium compared to the negative DMSO-control
(Fig 3). However, only cells exposed to 0.2 and 1.9 mg/L Triton X-100 resulted in visibly
Fig 2. Influence of the flame retardant DE-71 on thyroid specific gene expression. Cultures of human
thyrocytes were stimulated with 1 IU/TSH and in absence or presence of DE-71, at different concentrations.
After 72 hours, expression of thyroglobulin (Tg), thyroid stimulated hormone receptor (TSHr), thyroid
peroxidase (TPO), interleukin-6 (IL-6) and sodium iodide symporter (NIS) genes were measured by RT-
qPCR. Shown are mean+SD of the ratio of quantified mRNA normalized to housekeeping gene to the
negative control (control = 1; dotted line) for five experiments. *p<0.05 for the null-hypothesis that DE-71 had
no effect.
https://doi.org/10.1371/journal.pone.0179858.g002
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affected cells by light microscopy. The cells had loosened from the vials and were fewer in
number. The analyses were done on cell supernatants, which might include cell fragments, but
adherent cell fractions were not included in the analysis.
At concentrations of 50 mg DE-71/L and 10 mg DE-71/L, DE-71 appeared to have some
cytotoxic effect, indicated by an increase in supernatant LDH concentration compared to the
DMSO control. However, the induced LDH release was lower than that induced by the lowest
positive Triton X-100 control.
PBDE analysis
The concentration of PBDE congeners in the supernatants and in the cells was close to added
concentrations (Table 6). The vast majority of DE-71 added to thyrocyte cultures was found in
the cell remnants. Thus, the concentration of DE-71 in cell supernatants, measured as the con-
centration of BDE-99, was only 0.2–1.8% of the added DE-71 concentration, while concentra-
tions of DE-71 in cell remnants were 95.1–110% of the added concentrations (Table 6). The
analyses of controls containing DMSO showed traces of BDE-99 (0.13 μg/L).
The DE-71 stock solutions mainly contained BDE-99 (50%), BDE-47 (29%), BDE-100
(9%), BDE-153 (5.1%) and BDE-154 (3.7%) (see [36]This pattern was similar in the superna-
tant and cells, however, with relatively more BDE-47 in the cells (23 ± 5.9%) than in the super-
natant (13 ± 3.0%), and relatively less BDE-154 and BDE-153.
The average recovery of the extracts and DE-71 standards was 90% (range: 75–105%) and
89% (range: 79–103%), respectively. One of the blanks contained traces of PBDEs at the level
of the detection limits. The PBDEs spiked to co-extracted control samples were recovered at
97% on average (n = 8), ranging from 91% for BDE-183 to 100% for BDE-66.
Table 5. ANOVA and Tukey honest significant difference post hoc results from RT-qPCR analysis, n = number of cultures, p-value comparing
gene expression between individual different DE-71 concentrations, statistically significant differences between the indicated groups are shown.
All other comparisons were not statistically significantly different and values are not shown. HSD: honest significant difference, Estimated difference: estimate
of individual difference/intercept in gene expression between the indicated DE-71 concentration exposures (groups) in TukeyHSD.
Gene n p-value ANOVA Transformed data used Significant p-value Tukey Groups compared Estimated difference (95% CI) Tukey
Tg 5 <0.0001 no 0.0091 Control– 1 mg/L DE-71 -0.98(-1.78;-0.19)
0.00012 Control– 5 mg/L DE-71 -1.42 (-2.22;-0.63)
0.00022 Control– 10 mg/L DE-71 -1.36 (-2.15;-0.56)
0.00024 Control– 50 mg/L DE-71 -1.35 (-2.14;-0.55)
0.0025 0.01–5 mg/L DE-71 -1.11 (-1.91;-0.32)
0.0046 0.01–10 mg/L DE-71 -1.05 (-1.84;-0.25)
0.0051 0.01–50 mg/L DE-71 -1.04 (-1.84;-0.25)
TPO 5 0.0029 no 0.013 Control– 5 mg/L DE-71 -1.18 (-2.17;-0.19)
0.013 Control– 10 mg/L DE-71 -1.18 (-2.17;-0.18)
0.046 0.01–5 mg/L DE-71 -1.01 (-2.00;-0.01)
0.047 0.01–10 mg/L DE-71 -1.00 (-2.00;-0.01)
TSHr 5 0.00014 no 0.0081 Control– 5 mg/L DE-71 -1.46 (-2.62;-0.29)
0.018 Control– 10 mg/L DE-71 -1.33 (-2.50;-0.16)
0.0044 Control– 50 mg/L DE-71 -1.55 (-2.72;-0.38)
0.028 0.01–50 mg/L DE-71 -1.26 (-2.43;-0.09)
0.0053 0.1–5 mg/L DE-71 -1.52 (-2.69;-0.35)
0.012 0.1–10 mg/L DE-71 -1.39 (-2.56;-0.23)
0.0029 0.1–50 mg/L DE-71 -1.61 (-2.78;-0.45)
IL-6 5 0.73 ln - - -
NIS 4 0.13 ln - - -
https://doi.org/10.1371/journal.pone.0179858.t005
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Discussion
An influence of EDCs on thyroid gland function has been suggested [18]. In the present study,
we examined the influence of the PentaBDE mixture DE-71 on cultures of human primary
Fig 3. Cytotoxicity of DE-71 in primary human thyrocytes; Lactate dehydrogenase (LDH) release from
human thyrocytes after DE-71 addition at six concentrations. LDH was measured in relative
fluorescence units (RFU), n = 1 culture; conc.: concentration, DMSO: dimethyl sulfoxide, PC = positive control
(Triton X-100).
https://doi.org/10.1371/journal.pone.0179858.g003
Table 6. Concentrations of DE-71 in supernatants and cells. Measured concentration of PBDE congeners (μg/L) in cells and supernatants in comparison
to added concentrations of DE-71. LOD: Limit of detection.
DE-71 congeners 0.01 mg DE-71/L 1 mg DE-71/L 50 mg DE-71/L
Supernatant Cells Supernatant Cells Supernatant
BDE-28 < LOD < LOD < LOD 0.94 < LOD
BDE-47 0.059 1.90 0.161 230 33.4
BDE-49 < LOD < LOD < LOD 4.02 0.715
BDE-66 < LOD 0.0930 < LOD 4.81 1.00
BDE-85 < LOD 0.240 < LOD 19.6 6.29
BDE-99 0.646 6.31 0.507 496 146
BDE-100 < LOD 1.21 0.0758 93.7 24.8
BDE-153 < LOD 0.972 0.148 56.3 26.4
BDE-154 < LOD 0.692 0.0636 44.8 17.7
ΣPBDE 0.124 11.4 0.955 951 257
ΣPBDE 11.5 951 49,532
https://doi.org/10.1371/journal.pone.0179858.t006
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thyroid cells grown in the presence or absence of TSH. We have previously shown that such
cultures contain 98% Tg-producing cells, confirming the thyroid cell identity [30], and that
TSH consistently increases cAMP release [37]. In this study we used Tg protein concentrations
as surrogate marker of the ability of the cultured thyroid cells to secrete T3 and T4. The actual
ability of the cell to produce the hormones is rather low, as previously found by our group
(unpublished results). This is probably due to absence of iodine in the culture media, to the
use of the cells in a non-polarized way [38] or due to cell arrangement in a monolayer com-
pared to colloid rich follicles. Thyroid cell arrangement is different in vitro compared to in
vivo (monolayer compared to colloid rich follicles). We therefore did not include measure-
ments of these hormones in the present experimental set-up.
The main congeners of DE-71 were determined by GC-MS-analysis and were in agreement
with the profile of DE-71 specified by La Guardia et al. [10]. The GC-MS analysis confirmed
that the amount of PBDEs added to the assays was available in the cell cultures, i.e. no major
loss occurred through e.g. adsorption or degradation.
Of key importance, we found that DE-71 inhibited the thyrocyte production of Tg in a two
phase response manner and cAMP in a concentration-dependent manner. Furthermore, the
expression of mRNA encoding Tg, TPO, and TSHr was also reduced by DE-71. Tg protein
production and Tg gene expression seemed to be inhibited in a parallel manner. By contrast,
expression of NIS was not significantly affected by DE-71, but appeared inhibited in a pattern
similar to the inhibition of Tg, TPO and TSHr supporting the general inhibiting tendency of
DE-71. However, the expression levels of NIS were low at baseline, why there is an uncertainty
related to the expression levels of NIS. As expected, the expression of IL-6 was insignificant
confirming identity of the cells as differentiated thyrocytes. As previously shown, IL-6 levels
are expected to be lower in the TSH-stimulated control than in the unstimulated control [39].
The absolute change in gene expression may appear modest and this should be taken into
account. Some of this could be due to the large between culture variation in human primary
thyroid cell cultures [30]. However, the gene expression results are supported by the decreased
protein levels found in the Tg and cAMP analysis which brings biological significance to the
affected gene expression pathways.
The mechanisms by which absorbed PBDEs act on the human thyroid homeostasis have
not been clarified [19;24]. Suggestions include induction of uridine diphosphate
glucuronyltransferase (UDPGT) activity [28;29], direct thyroid tissue attack, alterations in
transport of thyroid hormones and hormone deactivation [16]. Furthermore, the chemical
structure of PBDEs is very similar to the structure of the thyroid hormone T4 [13]. Thus, a
competitive effect of the PBDEs on the thyroid hormone receptor is suspected, but the poten-
tial of such a mechanism is unknown [40]. Hence, multiple thyroid related endpoints impacted
by PBDE exposure probably exist. No previous research has investigated the direct effects of
DE-71 on thyrocytes. The combination of inhibited gene expression and protein production
found in this study supports the hypothesis that DE-71 inhibits thyrocyte function by direct
thyroid attack. This inhibition could be compared to that of the proinflammatory cytokine IL-
1β. IL-1β was used as a positive control as it has consistently been shown to inhibit the differ-
entiated function of thyroid cells (reviewed in [41]) in the same assay as the one in the present
study [31;39;42;43]. Though direct comparison between previous studies and the present DE-
71 study is not possible, since cells from different individuals have been used, the grade for
DE-71 inhibition shown here is comparable to the one induced by IL-1β, albeit possibly at
higher concentrations for DE-71 indicating a lower potency of DE-71 compared to IL-1β.
However, the grade of DE-71 inhibition shown here seems to be as potent to the inhibition
induced by IL-1β, at least for Tg and cAMP secretion, and Tg-, TPO- and TSHr-gene
expression.
DE-71 inhibits human thyroid cell function
PLOS ONE | https://doi.org/10.1371/journal.pone.0179858 June 23, 2017 12 / 18
In summary, multiple studies in other model systems have found DE-71 to be thyrotoxic.
Overall the mode of action is presumed to be a combination of induction of liver enzymes and
displacement of thyroid hormones from serum transport proteins together affecting the excre-
tion of thyroid hormones [16;28;29]. As these pathways are not present in this assay the effect
of DE-71 on the thyrocytes could be through different mechanisms, potentially adding a new
mode of action to DE-71.
Correlations between thyroid disturbances and PBDEs in humans have been described epi-
demiologically. One study showed significantly higher PBDE levels in umbilical cord blood
and breast milk samples from mothers with a history of thyroid disease compared to healthy
mothers [44], and another study suggested a correlation between congenital hypothyroidism
and PBDEs in the serum [45], while Jacobson et al. found higher TSH and lower T4 concentra-
tions among toddlers [46]. In 2016 Oulhote et al. found a positive association between reported
hypothyroidism in women (aged 30–79 years) and the sum of PBDEs and BDE-47 alone in
serum, however not significant for other BDEs [47]. Other disturbances in thyroid hormone
concentrations correlating to PBDE-levels have been described as well [48;49]. This indicates
an increased risk for disease in presence of higher blood PBDE-levels. Our findings support
this notion. However, the causality of the correlation was questioned by Eggesbø et al. [50],
who did not observe an association between TSH concentrations in whole blood of neonates
and the PBDE concentrations in their mothers’ milk. In addition, Julander et al. found no sig-
nificant increases in plasma PBDE concentrations with increasing length of exposure in a
high-risk group (workers at an electronic recycling facility), and no significant correlations to
thyroid hormone-concentrations [51]. They did, however, find a tendency to negative associa-
tions between free T4 and serum levels of BDE-28, BDE-153 and BDE-183. In conclusion, epi-
demiological studies have not given consistent results, as the studies have used varying
endpoints, exposures and methods.
More consistent results have been obtained from animal studies. Several in vivo rodent
studies have pointed towards a thyroid hormone disturbance after PBDE-exposure, where
lowered concentrations of T4 were the most frequent and significant finding [28;29;52–55].
Three of six studies found no changes in T3 levels in mice and rats [28;29;54], three studies
measured TSH [28;54;55] where only one found an effect, and only in male rats [55]. However,
all animal studies found significantly reduced T4 levels after exposure to PBDE. In addition
de-Miranda et al. found decreased T4-serum concentrations in postnatal rats exposed to DE-
71 with a reversible effect by adding T4 [56].
In line with our findings, another in vitro study revealed inhibited thyroid hormone-
dependent Purkinje cell development after addition of DE-71 in two doses (10−10 M and
10−8 M) in the developing rat cerebellum [57].
In general, PBDE-doses used in animal experiments and measured exposure levels are diffi-
cult to compare with the concentrations of this study due to differences in units, the number
of included congeners and method differences [1;12;58–60]. Our experiments were performed
in serum-free conditions and thus the free PBDE concentrations may be lower in vivo where
serum binding proteins for PBDE are present. The concentration range of DE-71 used in this
study were similar to former in vitro studies with PBDEs [61;62]. The lowest concentration of
DE-71 used in our study was 0.01 mg DE-71/L. As BDE-47 accounted for 29% of DE-71, this
resulted in a concentration of BDE-47 of 2.9 μg/L, which is approximately 10–20 times higher
than a typical median concentration of BDE-47 in serum of the US population. The levels in
the general population of Europe are about 10 times lower than the US body burdens [1;12].
However, the distributions are usually highly skewed with medians clearly lower than arithme-
tic means, reflecting higher internal exposure levels in some individuals, which likely are closer
to the concentrations used in this study. Animal experiments showing responses of the thyroid
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systems tend to use doses above that of this study [e.g. [55]], but rarely determine serum con-
centrations. The exposure doses usually exceed estimates of human exposure by several orders
of magnitude [63].
In view of the above, our in vitro results should be extrapolated to in vivo actions with cau-
tion. There are a limited number of target sites and toxicity pathways in cells in vitro compared
to the amount of target sites in an organ/multi-organ system, with many interactions and feed-
back systems [64]. In addition, it is not known, whether DE-71 accumulates intracellularly,
which is possible since half-life ranges are long and PBDEs are highly lipophilic. The congener
assessment showed orders of magnitude lower concentrations in the cell supernatants after
ended experiments. Afterwards, we recovered the DE-71 concentrations added to cells in the
respective cell remnants of 95–110%, which is an almost complete recovery. This indicated an
intracellular accumulation of DE-71 or adhesion of DE-71 to the cells. Our measurements did
not distinguish between cellular uptake and attachment to cells. Due to the high lipophilicity
of DE-71, some of the compound may have attached to glassware and instruments during stor-
age and experiments, resulting in lower effective DE-71 concentrations than assumed. This
was, however, contradicted by the experiments recovering almost all of the added DE-71.
Hence, the observed effects on thyroid cell function were probably due to intracellular actions
of DE-71.
Thyrocytes leaked LDH at high DE-71 concentrations indicating a cytotoxic effect of DE-
71. However, all LDH-levels from DE-71 stimulated cell supernatants were below the lowest
positive Triton X-100 control, and the cells appeared viable by microscopy. Hence, we
assumed that the applied concentrations of DE-71 were not toxic to thyrocytes. However, it is
possible that DE-71 has cytotoxic effects at low levels, which might explain the tendency of a
no-dose dependent effect at higher DE-71 concentrations. It is highly relevant for future stud-
ies to examine this issue e.g. by other methods.
Although production of PBDEs is now prohibited and some studies have indicated stagna-
tions in exposure levels and in human and animal sera [1], the results reported here remain of
relevance, since the long half-lives of PBDEs and their continuous release from existing prod-
ucts may affect humans for many years [9]. Moreover, DecaBDE is still in production and can
be degraded to lower brominated diphenyl ethers [65;66]. New chemicals replacing the old
PBDEs are largely untested and may have the same chemical properties as the old ones includ-
ing toxicity and persistence [67].
Conclusion
DE-71 exerted a two-phase response of Tg and a concentration-dependent inhibition of cAMP
production from human thyrocytes as well as inhibition of the expression of the genes encod-
ing Tg, TSHr and TPO. Former human epidemiological studies found changed thyroid hor-
mone levels following exposure to DE-71, while animal studies found reduced
T4-concentrations. Our findings suggest an inhibiting effect of PBDEs on thyroid cells, which
may explain the disturbances of thyroid homeostasis found by others. Further investigations
regarding thyroid disturbances exerted by PBDEs in humans are needed. In addition, further
experiments are needed at a lower concentration spectrum of DE-71 or individual PBDE con-
geners. To predict systemic toxicological effects, in vivo studies with an in vivo design are
needed.
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